read
What actions should be taken after an ARN report is published?
ARN outcomes have no legal or regulatory relevance as they are not part of any formal regulatory management and decision-making processes. ARNs are developed voluntarily by the Agency and used as screening-level assessments to help the Commission and Member States understand if and where regulatory action might be needed.
ARN is a tool for early awareness and industry preparation. It is not a final assessment. Regulatory actions are initiated after thorough assessments by Member States and competent authorities through possibly issuing a compliance check (CCH) for further data collection and generation before potentially moving towards regulatory risk management.
As a registrant, it is important to stay informed on the published ARNs, keep the dossier up to date, for e.g. critical uses or any data that might result in potential regulatory implications, and proactively participate in the process.
How to keep informed about the ARNs published?
ECHA notifies affected registrants of published ARN reports via REACH-IT with a message that contains a direct link. ARN report updates are also shared in ECHA weekly newsletters.
SCC clearly recommends to keep track of possible ARNs on substances of interest and take immediate follow-up actions as recommended by Cefic. If you need help in better understanding the ARN process and keeping up to date with corrective actions, please contact This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it., Team Lead Chemicals Risk Assessment.
